- Telegraph Hill Partners invests in life science, medical technology and healthcare companies
- Founded in 2001, Telegraph Hill Partners is headquartered in San Francisco
- THP V will be managed by a team that includes Matt Mackowski, Deval Lashkari, Tom Raffin, Jeanette Welsh, Alex Efron, Kate Cilio and Linda Gregoire
Telegraph Hill Partners has closed its fifth fund at $525 million.
THP V will invest in companies that are commercializing advanced technologies in areas including life science tools, reagents, specialty chemistries, medical technology, medical devices, diagnostics, healthcare IT, healthcare services, agriculture and animal health.
THP V will be managed by a team that includes Matt Mackowski, Deval Lashkari, Tom Raffin, Jeanette Welsh, Alex Efron, Kate Cilio and Linda Gregoire in San Francisco; Paul Grossman in San Diego; Rob Hart in Miami; Alex Herzick and Rob Capone in Research Triangle Park; and Gary Curtis in New Haven.
“We are grateful to our limited partners for their continued support for our team and investment philosophy of building long-term value through company development,” stated Matt Mackowski, chairman of THP, in a statement. “We particularly thank the management and staff of our current and prior portfolio companies for their exceptional performance which enabled the formation of THP V, our largest fund since we formed Telegraph Hill Partners 21 years ago.”
Founded in 2001, Telegraph Hill Partners is headquartered in San Francisco.